Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.

[1]  C. McEvoy,et al.  Lifetime lung function trajectories and COPD: when the train derails. , 2022, The Lancet. Respiratory medicine.

[2]  Paul D. Thomas,et al.  Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study. , 2022, The Lancet. Respiratory medicine.

[3]  S. Salvi,et al.  The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review , 2022, The Lancet. Global health.

[4]  Meilan K. Han,et al.  Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function. , 2022, The New England journal of medicine.

[5]  P. Burney,et al.  Prevalence and risk factors for small airways obstruction: Results from the Burden of Obstructive Lung Disease (BOLD) study. , 2022, Epidemiology.

[6]  Meilan K. Han,et al.  Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission , 2022, The Lancet.

[7]  D. Mannino,et al.  Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for its Revision. , 2022, American journal of respiratory and critical care medicine.

[8]  I. Pavord,et al.  Treatable traits in the NOVELTY study , 2022, Respirology.

[9]  S. Fuke,et al.  Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial , 2022, American journal of respiratory and critical care medicine.

[10]  I. Pavord,et al.  Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A GOLD Science Committee 2022 Review. , 2022, American journal of respiratory and critical care medicine.

[11]  M. Martínez-García,et al.  Chronic Bronchial Infection Is Associated with More Rapid Lung Function Decline in COPD. , 2022, Annals of the American Thoracic Society.

[12]  A. Forsythe,et al.  Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses , 2022, Journal of asthma and allergy.

[13]  E. Wan.  The Clinical Spectrum of PRISm , 2022, American journal of respiratory and critical care medicine.

[14]  A. Koczulla,et al.  Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial , 2022, Thorax.

[15]  A. Shoemark,et al.  Endotyping COPD, Bronchiectasis and the 'COPD-bronchiectasis Association'. , 2022, American journal of respiratory and critical care medicine.

[16]  Yi Zhang,et al.  High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial , 2022, Critical Care.

[17]  F. Maltais,et al.  Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study , 2022, American journal of respiratory and critical care medicine.

[18]  A. Agustí,et al.  Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. , 2022, The Lancet. Respiratory medicine.

[19]  E. Silverman,et al.  Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder. , 2022, The Lancet. Respiratory medicine.

[20]  C. Jenkins,et al.  Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. , 2022, The Lancet. Respiratory medicine.

[21]  K. Balakrishnan,et al.  Household air pollution and COPD: cause and effect or confounding by other aspects of poverty? , 2022, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[22]  B. Celli,et al.  Chest CT‐assessed comorbidities and all‐cause mortality risk in COPD patients in the BODE cohort , 2022, Respirology.

[23]  M. Miravitlles,et al.  Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis. , 2022, Pulmonary pharmacology & therapeutics.

[24]  D. Halpin,et al.  A Systematic Review of Published Algorithms for Selecting an Inhaled Delivery System in COPD. , 2021, Annals of the American Thoracic Society.

[25]  Z. Ademi,et al.  Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis , 2021, BMJ.

[26]  Meilan K. Han,et al.  Treatment Trials in Pre-COPD and Young COPD: Time to Move Forward. , 2021, American journal of respiratory and critical care medicine.

[27]  A. Sheikh,et al.  Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes , 2021, European Respiratory Journal.

[28]  C. Gregoretti,et al.  ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure , 2021, European Respiratory Journal.

[29]  A. Agustí,et al.  Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial. , 2021, JAMA.

[30]  J. Wedzicha,et al.  An Updated Definition and Severity Classification of COPD Exacerbations: The Rome Proposal. , 2021, American journal of respiratory and critical care medicine.

[31]  Y. Lacasse,et al.  Oximetry neither to prescribe long-term oxygen therapy nor to screen for severe hypoxaemia , 2021, ERJ Open Research.

[32]  M. Miravitlles,et al.  Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis , 2021, PloS one.

[33]  A. Ramírez-Venegas,et al.  The “Slow Horse Racing Effect” on Lung Function in Adult Life in Chronic Obstructive Pulmonary Disease Associated to Biomass Exposure , 2021, Frontiers in Medicine.

[34]  B. Nordestgaard,et al.  Supernormal lung function and risk of COPD: A contemporary population-based cohort study , 2021, EClinicalMedicine.

[35]  P. Ran,et al.  Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis , 2021, Annals of translational medicine.

[36]  C. Tromeur,et al.  Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms. , 2021, JAMA.

[37]  M. Sjoding,et al.  Racial Bias in Pulse Oximetry Measurement. , 2020, The New England journal of medicine.

[38]  B. Nordestgaard,et al.  Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study , 2020, European Respiratory Journal.

[39]  J. Wedzicha,et al.  From GOLD 0 to Pre-COPD , 2020, American journal of respiratory and critical care medicine.

[40]  Sally J. Singh,et al.  Predictors of Referral to Pulmonary Rehabilitation from UK Primary Care , 2020, International journal of chronic obstructive pulmonary disease.

[41]  F. Martinez,et al.  Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease , 2020, American journal of respiratory and critical care medicine.

[42]  B. Nordestgaard,et al.  Importance of Early COPD In Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study. , 2020, American journal of respiratory and critical care medicine.

[43]  T Kashiwagi,et al.  What is palliative care? , 2020, InnovAiT: Education and inspiration for general practice.

[44]  N. Thakur,et al.  Reassessment of Home Oxygen Prescription after Hospitalization for COPD: A Potential Target for De-implementation. , 2020, Annals of the American Thoracic Society.

[45]  G. Washko,et al.  Phenotypic characterisation of early COPD: a prospective case–control study , 2020, ERJ Open Research.

[46]  M. Montes de Oca.  Smoking Cessation/Vaccinations. , 2020, Clinics in chest medicine.

[47]  M. Miravitlles,et al.  Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review , 2020, European Respiratory Review.

[48]  P. Dorinsky,et al.  Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD. , 2020, The New England journal of medicine.

[49]  Benjamin M. Smith,et al.  Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults. , 2020, JAMA.

[50]  L. Kinsman,et al.  Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis , 2020, European Respiratory Review.

[51]  M. Steiner,et al.  Pulmonary rehabilitation at a time of social distancing: prime time for tele-rehabilitation? , 2020, Thorax.

[52]  R. Stockley.  Alpha-1 Antitrypsin Deficiency: The Learning Goes On , 2020, American journal of respiratory and critical care medicine.

[53]  Meilan K. Han,et al.  Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients. , 2020, American journal of respiratory and critical care medicine.

[54]  N. Chavannes,et al.  Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial , 2014, BMJ : British Medical Journal.

[55]  Harry J de Koning,et al.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.

[56]  A. Agustí,et al.  BRONCHIAL INFECTION AND temporal evolution OF bronchiectasis in patients with chronic obstructive pulmonary disease. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  G. Tikellis,et al.  Home-based or remote exercise testing in chronic respiratory disease, during the COVID-19 pandemic and beyond: A rapid review , 2020, medRxiv.

[58]  E. Kerwin,et al.  Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial , 2019, Respiratory Research.

[59]  J. Hogg,et al.  Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. , 2019, The New England journal of medicine.

[60]  P. Cullinan,et al.  The occupations at increased risk of COPD: analysis of lifetime job-histories in the population-based UK Biobank Cohort , 2019, European Respiratory Journal.

[61]  David Couper,et al.  Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality. , 2019, JAMA.

[62]  A. Agustí,et al.  Lung function trajectories in health and disease. , 2019, The Lancet. Respiratory medicine.

[63]  N. Seersholm,et al.  COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months , 2019, BMJ Open Respiratory Research.

[64]  M. Weatherall,et al.  Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial , 2018, BMC Pulmonary Medicine.

[65]  B. Make,et al.  Women manifest more severe COPD symptoms across the life course , 2018, International journal of chronic obstructive pulmonary disease.

[66]  I. Farver-Vestergaard,et al.  Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis , 2018, BMC Pulmonary Medicine.

[67]  K. Rabe,et al.  Inhaled corticosteroids in COPD: friend or foe? , 2018, European Respiratory Journal.

[68]  J. Wedzicha,et al.  At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease , 2018, American journal of respiratory and critical care medicine.

[69]  J. Alison,et al.  Telerehabilitation for chronic respiratory disease , 2018, Cochrane Database of Systematic Reviews.

[70]  Meilan K. Han,et al.  Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS , 2018, Annals of the American Thoracic Society.

[71]  Meilan K. Han,et al.  Once‐Daily Single‐Inhaler Triple versus Dual Therapy in Patients with COPD , 2018, The New England journal of medicine.

[72]  N. Roche,et al.  Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial , 2018, The Lancet.

[73]  Cui Guo,et al.  Effect of long-term exposure to fine particulate matter on lung function decline and risk of chronic obstructive pulmonary disease in Taiwan: a longitudinal, cohort study. , 2018, The Lancet. Planetary health.

[74]  N. Meda,et al.  Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis , 2018, BMJ Open Respiratory Research.

[75]  J. Bigna,et al.  Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis. , 2017, The Lancet. Global health.

[76]  J. Brugada,et al.  Lung function in early adulthood and health in later life: a transgenerational cohort analysis. , 2017, The Lancet. Respiratory medicine.

[77]  J. Wedzicha,et al.  Combined Impact of Smoking and Early‐Life Exposures on Adult Lung Function Trajectories , 2017, American journal of respiratory and critical care medicine.

[78]  M. Stewart.  Postoperative Pulmonary Complications. , 2017, Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses.

[79]  B. Beghé,et al.  Chronic respiratory abnormalities in the multi-morbid frail elderly , 2017 .

[80]  Y. Li,et al.  Tiotropium in Early‐Stage Chronic Obstructive Pulmonary Disease , 2017, The New England journal of medicine.

[81]  M. Mirzaee,et al.  Prevalence and predictors associated with severe pulmonary hypertension in COPD , 2017, The American journal of emergency medicine.

[82]  G. A. Whitmore,et al.  Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction , 2017, American journal of respiratory and critical care medicine.

[83]  Joanna Picot,et al.  Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. , 2017, The Cochrane database of systematic reviews.

[84]  F. Martinez,et al.  Effect of roflumilast in patients with severe COPD and a history of hospitalisation , 2017, European Respiratory Journal.

[85]  Claus Vogelmeier,et al.  Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time , 2017, European Respiratory Journal.

[86]  P. Burney,et al.  The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study , 2017, European Respiratory Journal.

[87]  R. Suruki,et al.  Stability of Blood Eosinophil Count in Patients with COPD in the UK Clinical Practice Research Datalink , 2017, COPD.

[88]  E. Wouters,et al.  Cognitive impairment and clinical characteristics in patients with chronic obstructive pulmonary disease , 2017, Chronic respiratory disease.

[89]  E. Wouters,et al.  Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts. , 2017, American journal of respiratory and critical care medicine.

[90]  Dave Singh,et al.  Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial , 2017, The Lancet.

[91]  Giacomo Grasselli,et al.  Physiologic Effects of High‐Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure , 2017, American journal of respiratory and critical care medicine.

[92]  B. Cosío,et al.  Chronic Obstructive Pulmonary Disease in Non-Smokers. , 2017, Archivos de bronconeumologia.

[93]  R. Tang,et al.  Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis , 2016, International journal of chronic obstructive pulmonary disease.

[94]  A. Crockett,et al.  Should the diagnosis of COPD be based on a single spirometry test? , 2016, npj Primary Care Respiratory Medicine.

[95]  C. Mcevoy,et al.  Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study. , 2016, American journal of respiratory and critical care medicine.

[96]  E. Wouters,et al.  Domain-specific cognitive impairment in patients with COPD and control subjects , 2016, International journal of chronic obstructive pulmonary disease.

[97]  A. Torres,et al.  Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trial , 2016, European Respiratory Journal.

[98]  F. Martinez.  Early-Life Origins of Chronic Obstructive Pulmonary Disease. , 2016, The New England journal of medicine.

[99]  F. Burgos,et al.  Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations , 2016, Thorax.

[100]  K. Rabe,et al.  Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial. , 2016, American journal of respiratory and critical care medicine.

[101]  Meilan K. Han,et al.  Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. , 2016, American journal of respiratory and critical care medicine.

[102]  E. Papakonstantinou,et al.  Therapy with proton‐pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD , 2016, Respirology.

[103]  W. Guo,et al.  Body mass index and mortality in chronic obstructive pulmonary disease , 2016, Medicine.

[104]  D. Postma,et al.  Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. , 2016, The New England journal of medicine.

[105]  T. Troosters,et al.  Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement , 2016, European Respiratory Journal.

[106]  J. Masclans,et al.  Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure , 2016, Critical Care.

[107]  W. MacNee,et al.  Interventions to modify physical activity in patients with COPD: a systematic review , 2016, European Respiratory Journal.

[108]  J. Fraser,et al.  Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial , 2016, Thorax.

[109]  Hakan Günen,et al.  Waterpipe tobacco smoking. , 2016, Tuberkuloz ve toraks.

[110]  I. Pavord,et al.  Treatable traits: toward precision medicine of chronic airway diseases , 2016, European Respiratory Journal.

[111]  N. Anthonisen,et al.  Alteration in breathing pattern with progression of chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[112]  Dave Singh,et al.  Tiotropium + olodaterol shows clinically meaningful improvements in quality of life. , 2015, Respiratory medicine.

[113]  Melanie Irvin-sellers,et al.  Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease. , 2015, The Cochrane database of systematic reviews.

[114]  A. Malhotra,et al.  Reply: Sleep-Disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. , 2015, Annals of the American Thoracic Society.

[115]  Meilan K. Han,et al.  Clinical and Radiologic Disease in Smokers With Normal Spirometry. , 2015, JAMA internal medicine.

[116]  J. Wedzicha,et al.  Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease. , 2015, American journal of respiratory and critical care medicine.

[117]  M. Sadatsafavi,et al.  Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2015, The Lancet. Respiratory medicine.

[118]  N. Maimon,et al.  The Association Between Hospital Readmission and Pulmonologist Follow-up Visits in Patients With COPD. , 2015, Chest.

[119]  Ciro Casanova,et al.  COPD comorbidities network , 2015, European Respiratory Journal.

[120]  J. Soriano,et al.  Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. , 2015, The New England journal of medicine.

[121]  I. Pavord,et al.  Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. , 2015, The Lancet. Respiratory medicine.

[122]  F. Martinez,et al.  Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial , 2015, The Lancet.

[123]  G. Diette,et al.  Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease. , 2015, American journal of respiratory and critical care medicine.

[124]  J. Bourbeau,et al.  Clinical Relevance of Fixed Ratio vs Lower Limit of Normal of FEV1/FVC in COPD: Patient-Reported Outcomes From the CanCOLD Cohort , 2015, The Annals of Family Medicine.

[125]  J. Hallas,et al.  Gastro‐esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease , 2015, Respirology.

[126]  J. Walters,et al.  Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. , 2014, The Cochrane database of systematic reviews.

[127]  Thierry Troosters,et al.  An official European Respiratory Society statement on physical activity in COPD , 2014, European Respiratory Journal.

[128]  Jun She,et al.  Chinese water-pipe smoking and the risk of COPD. , 2014, Chest.

[129]  M. Decramer,et al.  Withdrawal of inhaled glucocorticoids and exacerbations of COPD. , 2014, The New England journal of medicine.

[130]  Stefano Nava,et al.  Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. , 2014, The Lancet. Respiratory medicine.

[131]  J. E. Hansen,et al.  Counterpoint: Is an increase in FEV₁ and/or FVC ≥ 12% of control and ≥ 200 mL the best way to assess positive bronchodilator response? No. , 2014, Chest.

[132]  Edwin K Silverman,et al.  Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene , 2014, Respiratory Research.

[133]  Meilan K. Han,et al.  Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. , 2014, American journal of respiratory and critical care medicine.

[134]  D. Mannino,et al.  Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013 , 2014, International journal of chronic obstructive pulmonary disease.

[135]  E. Regan,et al.  Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort , 2014, Respiratory Research.

[136]  J. Vonk,et al.  Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study , 2014, Thorax.

[137]  N. Horita,et al.  Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease , 2014, Respiratory Research.

[138]  R. Rodríguez-Roisín,et al.  Disease progression in young patients with COPD: rethinking the Fletcher and Peto model , 2014, European Respiratory Journal.

[139]  G. Pledger,et al.  Tiotropium Respimat Inhaler and the Risk of Death in COPD , 2014 .

[140]  Kayleigh Kew,et al.  Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. , 2014, The Cochrane database of systematic reviews.

[141]  W. Vincken,et al.  Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study , 2014, International journal of chronic obstructive pulmonary disease.

[142]  J. Dhaliwal.  High-dose N-acetylcysteine in Stable COPD: The 1-year, Double-blind, Randomized, Placebo-controlled HIACE Study , 2014 .

[143]  Y. Lacasse,et al.  Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis. , 2014, Respiratory medicine.

[144]  M. Decramer,et al.  Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study , 2013, European Respiratory Journal.

[145]  A. Sheikh,et al.  Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial , 2013, BMJ.

[146]  N. Chavannes,et al.  Integrated disease management interventions for patients with chronic obstructive pulmonary disease. , 2013, The Cochrane database of systematic reviews.

[147]  A. Church,et al.  Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD. , 2013, Respiratory medicine.

[148]  L. Edwards,et al.  Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. , 2013, Respiratory medicine.

[149]  Emmylou Beekman,et al.  Course length of 30 metres versus 10 metres has a significant influence on six-minute walk distance in patients with COPD: an experimental crossover study. , 2013, Journal of physiotherapy.

[150]  A. Santarelli,et al.  Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention. , 2013, Chest.

[151]  H. Tange,et al.  Early detection of COPD in general practice: implementation, workload and socioeconomic status. A mixed methods observational study , 2013, Primary Care Respiratory Journal: Journal of the General Practice Airways Group.

[152]  S. Laporte,et al.  Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry , 2013, Respiratory Research.

[153]  C. Caracta,et al.  Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study , 2013, COPD.

[154]  M. Briel,et al.  Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. , 2013, JAMA.

[155]  E. Bateman,et al.  Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study , 2013, European Respiratory Journal.

[156]  J. Wedzicha,et al.  Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. , 2013, The Lancet. Respiratory medicine.

[157]  James D. Chalmers,et al.  Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. , 2013, Annals of the American Thoracic Society.

[158]  M. Martínez-García,et al.  Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[159]  P. Bower,et al.  The Effect of Complex Interventions on Depression and Anxiety in Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis , 2013, PloS one.

[160]  B. Beghé,et al.  Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD , 2013, European Respiratory Journal.

[161]  L. Edwards,et al.  Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. , 2013, American journal of respiratory and critical care medicine.

[162]  P. Jones,et al.  COPD Assessment Test –Rationale, Development, Validation and Performance , 2013, COPD.

[163]  E. Bateman,et al.  Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study. , 2013, The Lancet. Respiratory medicine.

[164]  J. Barberà,et al.  Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial , 2013, European Respiratory Journal.

[165]  N. Roche,et al.  High-risk patients following hospitalisation for an acute exacerbation of COPD , 2013, European Respiratory Journal.

[166]  L. Bisanti,et al.  Air pollution and multiple acute respiratory outcomes , 2013, European Respiratory Journal.

[167]  P. Jones,et al.  Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification , 2012, European Respiratory Journal.

[168]  S. Ramsey,et al.  End-of-life care in the intensive care unit: can we simultaneously increase quality and reduce costs? , 2012, American journal of respiratory and critical care medicine.

[169]  B. Celli,et al.  Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[170]  D. Mannino,et al.  Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. , 2012, American journal of respiratory and critical care medicine.

[171]  F. Maltais,et al.  Walking exercise response to bronchodilation in mild COPD: a randomized trial. , 2012, Respiratory Medicine.

[172]  Reinier Akkermans,et al.  Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial , 2012, BMJ : British Medical Journal.

[173]  P. Enright,et al.  Call for worldwide withdrawal of tiotropium Respimat mist inhaler , 2012, BMJ : British Medical Journal.

[174]  J. Soriano,et al.  Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. , 2012, Chest.

[175]  Martijn A Spruit,et al.  Short term and long term effects of pulmonary rehabilitation on physical activity in COPD. , 2012, Respiratory medicine.

[176]  T. Gislason,et al.  Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries , 2012, International journal of chronic obstructive pulmonary disease.

[177]  T. Lasserson,et al.  Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. , 2012, The Cochrane database of systematic reviews.

[178]  P. Poole,et al.  Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. , 2012, The Cochrane database of systematic reviews.

[179]  P. Lindenauer,et al.  Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension , 2012, Thorax.

[180]  E. Kerwin,et al.  Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study , 2012, European Respiratory Journal.

[181]  F. Maltais,et al.  Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease. , 2012, The American journal of cardiology.

[182]  Christopher E Brightling,et al.  Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. , 2012, American journal of respiratory and critical care medicine.

[183]  L. Edwards,et al.  Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease , 2012, Thorax.

[184]  Ella A. Kazerooni,et al.  CT-based Biomarker Provides Unique Signature for Diagnosis of COPD Phenotypes and Disease Progression , 2012, Nature Medicine.

[185]  Michael Greenstone,et al.  Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. , 2012, The Cochrane database of systematic reviews.

[186]  Dacheng Liu,et al.  Cause-specific mortality adjudication in the UPLIFT® COPD trial: findings and recommendations. , 2012, Respiratory medicine.

[187]  E. Kerwin,et al.  Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I) , 2012, COPD.

[188]  E. Bateman,et al.  Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study , 2012, European Respiratory Journal.

[189]  J Cleland,et al.  Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial , 2012, BMJ : British Medical Journal.

[190]  D. Au,et al.  A randomized trial to improve communication about end-of-life care among patients with COPD. , 2012, Chest.

[191]  Stefan Störk,et al.  "GOLD or lower limit of normal definition? a comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study" , 2012, Respiratory Research.

[192]  E. Kerwin,et al.  Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD , 2012, International journal of chronic obstructive pulmonary disease.

[193]  M. Decramer,et al.  High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease , 2012, Annals of Internal Medicine.

[194]  K. Hirata,et al.  Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial , 2011, Respiratory research.

[195]  A. Anzueto,et al.  Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. , 2011, Archives of internal medicine.

[196]  M. Cosio,et al.  Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors. , 2011, American journal of respiratory and critical care medicine.

[197]  M. Tsukino,et al.  Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease , 2011, International journal of chronic obstructive pulmonary disease.

[198]  J. Rozman,et al.  Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial. , 2011, Respiratory medicine.

[199]  P. Adab,et al.  Gender differences in COPD: are women more susceptible to smoking effects than men? , 2011 .

[200]  T. To,et al.  Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study , 2011, The Lancet.

[201]  John Connett,et al.  Azithromycin for prevention of exacerbations of COPD. , 2011, The New England journal of medicine.

[202]  A. Simonds,et al.  Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations , 2011, Thorax.

[203]  E. Regan,et al.  Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. , 2011, American journal of respiratory and critical care medicine.

[204]  P. Jones,et al.  Creating scenarios of the impact of copd and their relationship to copd assessment test (CAT™) scores , 2011, BMC pulmonary medicine.

[205]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[206]  S. Middleton,et al.  Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice , 2011, The Medical journal of Australia.

[207]  P. Enright,et al.  Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials , 2011, BMJ : British Medical Journal.

[208]  J. Lammers,et al.  Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. , 2011, Respiratory medicine.

[209]  R. Cavallazzi,et al.  Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies , 2011, Thorax.

[210]  K. Rabe.  Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease , 2011, British journal of pharmacology.

[211]  Louise Marston,et al.  Outdoor air pollution and respiratory health in patients with COPD , 2011, Thorax.

[212]  D. Jarvis,et al.  Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. , 2011, American journal of respiratory and critical care medicine.

[213]  E. Akl,et al.  Effects of water-pipe smoking on lung function: a systematic review and meta-analysis. , 2011, Chest.

[214]  K. Rabe,et al.  Tiotropium versus salmeterol for the prevention of exacerbations of COPD. , 2011, The New England journal of medicine.

[215]  Patrick D Mitchell,et al.  Hypoxemia in patients with COPD: cause, effects, and disease progression , 2011, International journal of chronic obstructive pulmonary disease.

[216]  M. Polkey,et al.  The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study , 2011, Thorax.

[217]  J. Vestbo,et al.  Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. , 2011, American journal of respiratory and critical care medicine.

[218]  T. Seemungal,et al.  Reported pneumonia in patients with COPD: findings from the INSPIRE study. , 2011, Chest.

[219]  S. Rennard,et al.  Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. , 2011, Chest.

[220]  J. Walusiak‐Skorupa,et al.  Faculty Opinions recommendation of COPD in never smokers: results from the population-based burden of obstructive lung disease study. , 2011 .

[221]  A. Justice,et al.  HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. , 2011, American journal of respiratory and critical care medicine.

[222]  J. Vestbo,et al.  Cardiovascular Morbidity in COPD: A Study of the General Population , 2011, COPD.

[223]  R. Rodríguez-Roisín,et al.  Antibiotics for exacerbations of chronic obstructive pulmonary disease. , 2011, The Cochrane database of systematic reviews.

[224]  Josep Roca,et al.  Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes , 2010, Thorax.

[225]  M Cazzola,et al.  Symptom variability in patients with severe COPD: a pan-European cross-sectional study , 2010, European Respiratory Journal.

[226]  G. Wesseling,et al.  Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire. , 2010, Respiratory medicine.

[227]  F. Maltais,et al.  Effects of written action plan adherence on COPD exacerbation recovery , 2010, Thorax.

[228]  L. Fabbri,et al.  Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents , 2010, Respiratory research.

[229]  R. Wood‐Baker,et al.  Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial , 2010, BMJ : British Medical Journal.

[230]  J. Vestbo,et al.  Management and survival of patients admitted with an exacerbation of COPD: Comparison of two Danish patient cohorts , 2010, The clinical respiratory journal.

[231]  L. Denehy,et al.  A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia , 2010, Thorax.

[232]  G. McLennan,et al.  A randomized study of endobronchial valves for advanced emphysema. , 2010, The New England journal of medicine.

[233]  J. Lammers,et al.  Detecting exacerbations using the Clinical COPD Questionnaire , 2010, Health and quality of life outcomes.

[234]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[235]  T. Michele,et al.  The safety of tiotropium--the FDA's conclusions. , 2010, The New England journal of medicine.

[236]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[237]  Yasutaka Nakano,et al.  CT scan findings of emphysema predict mortality in COPD. , 2010, Chest.

[238]  Edwin K Silverman,et al.  An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[239]  R. Sudore,et al.  Redefining the “Planning” in Advance Care Planning: Preparing for End-of-Life Decision Making , 2010, Annals of Internal Medicine.

[240]  R. Dahl,et al.  Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison , 2010, European Respiratory Journal.

[241]  J. Soriano,et al.  Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. , 2010, American journal of respiratory and critical care medicine.

[242]  U. Aguirre,et al.  Impact of changes in physical activity on health-related quality of life among patients with COPD , 2010, European Respiratory Journal.

[243]  C. Jenkins,et al.  Cardiovascular events in patients with COPD: TORCH Study results , 2010, Thorax.

[244]  J. Lötvall,et al.  Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. , 2010, American journal of respiratory and critical care medicine.

[245]  B. Make,et al.  Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. , 2010, Chest.

[246]  J. Vestbo,et al.  The prognostic importance of lung function in patients admitted with heart failure , 2010, European journal of heart failure.

[247]  R. Hoogenveen,et al.  Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach , 2010, European Respiratory Journal.

[248]  P. Davies,et al.  Tuberculosis, bronchiectasis and chronic airflow obstruction , 2010, Respirology.

[249]  P. Macdonald,et al.  Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. , 2010, Journal of the American College of Cardiology.

[250]  C. Hersh.  Faculty Opinions recommendation of Genome-wide association study identifies five loci associated with lung function. , 2010 .

[251]  P. Jones,et al.  Cognitive function in COPD , 2010, European Respiratory Journal.

[252]  G. Cooke,et al.  MMP12, lung function, and COPD in high-risk populations. , 2010, The New England journal of medicine.

[253]  T. Omachi,et al.  Influence of anxiety on health outcomes in COPD , 2010, Thorax.

[254]  D. Tashkin.  Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety , 2010, Current opinion in pulmonary medicine.

[255]  P. Mazzone.  Preoperative evaluation of the lung cancer resection candidate , 2010, Expert review of respiratory medicine.

[256]  Christoph Lange,et al.  Variants in FAM13A are associated with chronic obstructive pulmonary disease , 2010, Nature Genetics.

[257]  Eric A. Hoffman,et al.  Percent emphysema, airflow obstruction, and impaired left ventricular filling. , 2010, The New England journal of medicine.

[258]  J. Wedzicha,et al.  Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial , 2010, Respiratory research.

[259]  J. Hallas,et al.  Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study , 2010, The clinical respiratory journal.

[260]  Colin Simpson,et al.  Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland , 2010, European journal of heart failure.

[261]  Niels H Chavannes,et al.  Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. , 2009, American journal of respiratory and critical care medicine.

[262]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[263]  C. Jenkins,et al.  Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. , 2009, Chest.

[264]  D. Warburton,et al.  Can increased understanding of the role of lung development and aging drive new advances in chronic obstructive pulmonary disease? , 2009, Proceedings of the American Thoracic Society.

[265]  Byron C. Wallace,et al.  The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. , 2009, Human molecular genetics.

[266]  H. Gunen,et al.  Venous thromboemboli and exacerbations of COPD , 2009, European Respiratory Journal.

[267]  T. Welte,et al.  Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.

[268]  M. Decramer,et al.  Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial , 2009, The Lancet.

[269]  Omar Masera,et al.  Improved biomass stove intervention in rural Mexico: impact on the respiratory health of women. , 2009, American journal of respiratory and critical care medicine.

[270]  J. Nicolás,et al.  Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial , 2009, The Lancet.

[271]  G. Filippatos,et al.  Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .

[272]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[273]  F. Martinez,et al.  Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials , 2009, The Lancet.

[274]  F. Martinez,et al.  Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials , 2009, The Lancet.

[275]  Ulrike Held,et al.  Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index , 2009, The Lancet.

[276]  K. Kuwano,et al.  A Randomized, Single‐Blind Study of Lansoprazole for the Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease in Older Patients , 2009, Journal of the American Geriatrics Society.

[277]  S. Guerra,et al.  Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk , 2009, Thorax.

[278]  J. McMurray,et al.  Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial , 2009, European journal of heart failure.

[279]  D. Mannino,et al.  The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. , 2009, American journal of respiratory and critical care medicine.

[280]  L. Goldman,et al.  ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) , 2009, European Respiratory Journal.

[281]  C. Jenkins,et al.  Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study , 2009, Respiratory research.

[282]  J. Soriano,et al.  Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities , 2009, Thorax.

[283]  S. V. van Eeden,et al.  Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease , 2009, International journal of chronic obstructive pulmonary disease.

[284]  Fan Wang,et al.  The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. , 2009, Cell stem cell.

[285]  J. Barberà,et al.  Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. , 2009, Journal of applied physiology.

[286]  P. Jones,et al.  Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results , 2009, European Respiratory Journal.

[287]  P. J. Barnes,et al.  Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.

[288]  W. Vollmer,et al.  Marijuana and chronic obstructive lung disease: a population-based study , 2009, Canadian Medical Association Journal.

[289]  K. Shianna,et al.  A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.

[290]  D. Sin,et al.  Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. , 2009, Chest.

[291]  S. Solomon,et al.  Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) , 2009, European journal of heart failure.

[292]  Scott T. Weiss,et al.  A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study , 2009, PLoS genetics.

[293]  C. Vogelmeier,et al.  Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study , 2009, Respiratory research.

[294]  Yoon K Loke,et al.  Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. , 2009, Archives of internal medicine.

[295]  P. Metcalf,et al.  COPD prevalence is increased in lung cancer, independent of age, sex and smoking history , 2009, European Respiratory Journal.

[296]  D. Tashkin,et al.  Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD , 2009, COPD.

[297]  P. Jones.  Health Status and the Spiral of Decline , 2009, COPD.

[298]  T. Seemungal,et al.  Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. , 2008, American journal of respiratory and critical care medicine.

[299]  T. Murphy,et al.  Infection in the pathogenesis and course of chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[300]  David J Murphy,et al.  Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2008, JAMA.

[301]  P. Laveneziana,et al.  Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD , 2008, Thorax.

[302]  C. Vogelmeier,et al.  Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. , 2008, Respiratory medicine.

[303]  M. Decramer,et al.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[304]  Nicola A Hanania,et al.  Anxiety and Depression in COPD: Current Understanding, Unanswered Questions, and Research Needs. , 2008, Chest.

[305]  D. Mannino,et al.  Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD , 2008, European Respiratory Journal.

[306]  V. Peinado,et al.  Pulmonary vascular involvement in COPD. , 2008, Chest.

[307]  C. Torp‐Pedersen,et al.  Chronic obstructive pulmonary disease in patients admitted with heart failure , 2008, Journal of internal medicine.

[308]  Deepti Malhotra,et al.  Decline in Nrf2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, Dj-1 , 2022 .

[309]  T. Omland,et al.  Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. , 2008, Respiratory medicine.

[310]  P. Calverley,et al.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.

[311]  K. Rabe,et al.  Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD. , 2008, Chest.

[312]  Majid Ezzati,et al.  Biomass fuels and respiratory diseases: a review of the evidence. , 2008, Proceedings of the American Thoracic Society.

[313]  J. Vestbo,et al.  COPD stage and risk of hospitalization for infectious disease. , 2008, Chest.

[314]  N. Zhong,et al.  Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study , 2008, The Lancet.

[315]  D. Jarvis,et al.  Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes , 2008, Thorax.

[316]  A. Ionescu,et al.  What community measurements can be used to predict bone disease in patients with COPD? , 2008, Respiratory medicine.

[317]  R. Casaburi,et al.  Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients , 2008, International journal of chronic obstructive pulmonary disease.

[318]  D. Brooks,et al.  Inspiratory Muscle Training Compared With Other Rehabilitation Interventions in Chronic Obstructive Pulmonary Disease: A SYSTEMATIC REVIEW UPDATE , 2008, Journal of cardiopulmonary rehabilitation and prevention.

[319]  D. Sin,et al.  Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. , 2008, Chest.

[320]  P. Wagner,et al.  Possible mechanisms underlying the development of cachexia in COPD , 2008, European Respiratory Journal.

[321]  D. Mannino,et al.  Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort , 2008, Thorax.

[322]  K. Rabe,et al.  Complex chronic comorbidities of COPD , 2008, European Respiratory Journal.

[323]  David G. Anderson,et al.  Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[324]  D. Postma,et al.  Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. , 2007, Chest.

[325]  G. Valdivia,et al.  Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America , 2007, European Respiratory Journal.

[326]  Henry Chrystyn,et al.  Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? , 2007, Respiratory medicine.

[327]  D. Harrison,et al.  Implications of prognostic pessimism in patients with chronic obstructive pulmonary disease (COPD) or asthma admitted to intensive care in the UK within the COPD and asthma outcome study (CAOS): multicentre observational cohort study , 2007, BMJ : British Medical Journal.

[328]  A. Sharafkhaneh,et al.  COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial , 2007, Psychological Medicine.

[329]  Katayoon Bahadori,et al.  Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review , 2007, International journal of chronic obstructive pulmonary disease.

[330]  C. Jiang,et al.  Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study , 2007, The Lancet.

[331]  Stefano Guerra,et al.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study , 2007, The Lancet.

[332]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[333]  J. Barberà,et al.  Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations. , 2007, American journal of respiratory and critical care medicine.

[334]  P. Weiner,et al.  Inspiratory muscle training in pulmonary rehabilitation program in COPD patients. , 2007, Respiratory medicine.

[335]  B. Celli,et al.  Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.

[336]  Shengming Liu,et al.  Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China , 2007, Thorax.

[337]  S. Rennard,et al.  The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[338]  Richard Casaburi,et al.  Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. , 2007, Chest.

[339]  H. Gunen,et al.  The role of nebulised budesonide in the treatment of exacerbations of COPD , 2007, European Respiratory Journal.

[340]  A. Shroyer,et al.  Updated evaluation of the cost-effectiveness of lung volume reduction surgery. , 2007, Chest.

[341]  B. Celli,et al.  The 6-min walking distance: long-term follow up in patients with COPD , 2007, European Respiratory Journal.

[342]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[343]  J. Concato,et al.  Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. , 2007, Archives of internal medicine.

[344]  T. Ng,et al.  Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. , 2007, Archives of internal medicine.

[345]  P. Laveneziana,et al.  Dyspnea and Activity Limitation in COPD: Mechanical Factors , 2007, COPD.

[346]  N. Anthonisen,et al.  Mortality in COPD: role of comorbidities , 2006, European Respiratory Journal.

[347]  B. Celli,et al.  Overall management of stable chronic obstructive pulmonary disease , 2006 .

[348]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[349]  J. Vestbo,et al.  Potential misclassification of causes of death from COPD , 2006, European Respiratory Journal.

[350]  N. Zhong,et al.  Positive benefits of theophylline in a randomized, double‐blind, parallel‐group, placebo‐controlled study of low‐dose, slow‐release theophylline in the treatment of COPD for 1 year , 2006, Respirology.

[351]  R. Wood‐Baker,et al.  Written action plans in chronic obstructive pulmonary disease increase appropriate treatment for acute exacerbations , 2006, Respirology.

[352]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[353]  B. Celli,et al.  Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. , 2006, Chest.

[354]  F. Martinez,et al.  Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. , 2006, The Annals of thoracic surgery.

[355]  E. Ernst,et al.  Herbal medicines for the treatment of COPD: a systematic review , 2006, European Respiratory Journal.

[356]  T. Lasserson,et al.  Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.

[357]  Martyn R Partridge,et al.  Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. , 2006, Chest.

[358]  Maria Aliani,et al.  Prescription bias and factors associated with improper use of inhalers. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[359]  Thierry Troosters,et al.  American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. , 2006, American journal of respiratory and critical care medicine.

[360]  J. Vestbo,et al.  COPD: the dangerous underestimate of 15% , 2006, The Lancet.

[361]  B. Forsberg,et al.  Shedding new light on wood smoke: a risk factor for respiratory health , 2006, European Respiratory Journal.

[362]  A. Agustí,et al.  Telomere shortening in smokers with and without COPD , 2006, European Respiratory Journal.

[363]  F. Ram.  Use of theophylline in chronic obstructive pulmonary disease: examining the evidence , 2006, Current opinion in pulmonary medicine.

[364]  J. Garcia-Aymerich,et al.  Wood smoke exposure and risk of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[365]  J. Curtis,et al.  Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. , 2006, Archives of internal medicine.

[366]  J. Curtis,et al.  Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease , 2006, Expert review of anti-infective therapy.

[367]  C. D. Mathers,et al.  Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.

[368]  C. Roberts,et al.  UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation , 2006, Thorax.

[369]  D. Meier,et al.  The growth of palliative care programs in United States hospitals. , 2005, Journal of palliative medicine.

[370]  B. Celli,et al.  Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. , 2005, The American journal of medicine.

[371]  A. Torres,et al.  Guidelines for the management of adult lower respiratory tract infections , 2005, European Respiratory Journal.

[372]  Cesar G Victora,et al.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.

[373]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[374]  E. Salpeter,et al.  Cardioselective beta-blockers for chronic obstructive pulmonary disease. , 2005, The Cochrane database of systematic reviews.

[375]  J. Muñoz,et al.  Clinical efficacy of anti-pneumococcal vaccination in patients with COPD , 2005, Thorax.

[376]  A. Hansell,et al.  Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. , 2005, Chest.

[377]  Fernando Holguin,et al.  Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. , 2005, Chest.

[378]  S. Aaron,et al.  Physiological changes during symptom recovery from moderate exacerbations of COPD , 2005, European Respiratory Journal.

[379]  F. Rutten,et al.  Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. , 2005, European heart journal.

[380]  Carolyn E Behrendt,et al.  Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. , 2005, Chest.

[381]  Thomas Similowski,et al.  Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. , 2005, Chest.

[382]  Kirk R. Smith,et al.  Maternal exposure to biomass smoke and reduced birth weight in Zimbabwe. , 2005, Annals of epidemiology.

[383]  A. Rahmel,et al.  The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[384]  J. V. van Noord,et al.  Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD , 2005, European Respiratory Journal.

[385]  E. Pehlivan,et al.  Factors affecting survival of hospitalised patients with COPD , 2005, European Respiratory Journal.

[386]  D. Johns,et al.  Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease , 2005, Thorax.

[387]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[388]  M. Martínez-García,et al.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[389]  D. Lawlor,et al.  Association of birth weight with adult lung function: findings from the British Women’s Heart and Health Study and a meta-analysis , 2005, Thorax.

[390]  M. Ezzati.  Indoor air pollution and health in developing countries , 2005, The Lancet.

[391]  D. Lomas,et al.  α1-antitrypsin deficiency , 2005, The Lancet.

[392]  P. Calverley,et al.  Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 2005, Thorax.

[393]  L. Trupin,et al.  Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease , 2005, Environmental health : a global access science source.

[394]  Thierry Troosters,et al.  Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[395]  M. Decramer,et al.  Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial , 2005, The Lancet.

[396]  A. Sheikh,et al.  Illness trajectories and palliative care , 2005, BMJ : British Medical Journal.

[397]  J. Erikssen,et al.  Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males , 2005, European Respiratory Journal.

[398]  Mark E Kunik,et al.  Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. , 2005, Chest.

[399]  R. Casaburi,et al.  Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. , 2005, Chest.

[400]  John Connett,et al.  The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality , 2005, Annals of Internal Medicine.

[401]  A. Ionescu,et al.  Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[402]  M. Nishimura,et al.  COPD in Japan: the Nippon COPD Epidemiology study , 2004, Respirology.

[403]  P. Palange,et al.  Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. , 2004, Journal of applied physiology.

[404]  P. Burgel,et al.  Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium , 2004, Thorax.

[405]  M. Polkey,et al.  Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study , 2004, BMJ : British Medical Journal.

[406]  J. Hogg,et al.  Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.

[407]  J. Wedzicha,et al.  Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[408]  Ki Moon Bang,et al.  Airflow obstruction attributable to work in industry and occupation among U.S. race/ethnic groups: a study of NHANES III data. , 2004, American journal of industrial medicine.

[409]  Stefano Guerra,et al.  Asthma as a risk factor for COPD in a longitudinal study. , 2004, Chest.

[410]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[411]  T. Seemungal,et al.  Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[412]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[413]  W. Dejsomritrutai,et al.  Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. , 2004, Chest.

[414]  B. Make,et al.  Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD , 2004, European Respiratory Journal.

[415]  G. Zeng,et al.  Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. , 2004, Chinese medical journal.

[416]  S. Spencer,et al.  Impact of preventing exacerbations on deterioration of health status in COPD , 2004, European Respiratory Journal.

[417]  Roger L. Brown,et al.  Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: a randomized, controlled trial. , 2004, Journal of the National Cancer Institute.

[418]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[419]  H. Warwick,et al.  Smoke - the Killer in the Kitchen: Indoor Air Pollution in Developing Countries , 2004 .

[420]  M. Christ-Crain,et al.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.

[421]  B. Celli,et al.  The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.

[422]  P. Calverley,et al.  Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.

[423]  Margareta Emtner,et al.  Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. , 2003, American journal of respiratory and critical care medicine.

[424]  S. Spencer,et al.  Withdrawal from treatment as an outcome in the ISOLDE study of COPD. , 2003, Chest.

[425]  R. Hubbard,et al.  Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey , 2003, BMJ : British Medical Journal.

[426]  B. Rowe,et al.  Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials , 2003, BMJ : British Medical Journal.

[427]  L. Trupin,et al.  The occupational burden of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[428]  R. Zuwallack,et al.  An evaluation of nebulized levalbuterol in stable COPD. , 2003, Chest.

[429]  Emiel F M Wouters,et al.  Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. , 2003, Chest.

[430]  S. Spencer,et al.  Bronchodilator reversibility testing in chronic obstructive pulmonary disease , 2003, Thorax.

[431]  I. Stiell,et al.  Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. , 2003, The New England journal of medicine.

[432]  J. Curtis,et al.  Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. , 2003, Chest.

[433]  K. N. Maranetra,et al.  Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[434]  E. Prescott,et al.  Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study , 2003, European Respiratory Journal.

[435]  J. Wedzicha,et al.  COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.

[436]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[437]  Onchee Yu,et al.  Effectiveness of pneumococcal polysaccharide vaccine in older adults. , 2003, The New England journal of medicine.

[438]  Martin J Connolly,et al.  Early mobilization with walking aids following hospital admission with acute exacerbation of chronic obstructive pulmonary disease , 2003, Clinical rehabilitation.

[439]  D. Tashkin,et al.  Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. , 2003, Chest.

[440]  R. Kaplan,et al.  Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. , 2003, American journal of respiratory and critical care medicine.

[441]  E. Wouters.  The burden of COPD in The Netherlands: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[442]  Kathleen Kreiss,et al.  American Thoracic Society Statement: Occupational contribution to the burden of airway disease. , 2003, American journal of respiratory and critical care medicine.

[443]  M. Tsukino,et al.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.

[444]  R. Pauwels,et al.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.

[445]  L. Corbetta,et al.  Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[446]  P. Jones,et al.  Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations , 2003, European Respiratory Journal.

[447]  R. Sansores,et al.  Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[448]  S. Antoniu,et al.  Hospitalizations and mortality in the Lung Health Study , 2002, Expert review of pharmacoeconomics & outcomes research.

[449]  J. van der Palen,et al.  Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. , 2002, American journal of respiratory and critical care medicine.

[450]  A. Buist,et al.  Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.

[451]  J. Higgins,et al.  A systematic review of the use of opioids in the management of dyspnoea , 2002, Thorax.

[452]  D Olivieri,et al.  Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial). , 2002, Respiratory medicine.

[453]  G. Marks,et al.  Primary care Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease , 2022 .

[454]  P. Jones,et al.  Oral theophylline for chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.

[455]  Ki Moon Bang,et al.  Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. , 2002, American journal of epidemiology.

[456]  J. Yates,et al.  Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[457]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[458]  G. Kwakkel,et al.  Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis , 2002, European Respiratory Journal.

[459]  John E Connett,et al.  Smoking and lung function of Lung Health Study participants after 11 years. , 2002, American journal of respiratory and critical care medicine.

[460]  M. Antonelli,et al.  Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial , 2002, Intensive Care Medicine.

[461]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[462]  I. Vogiatzis,et al.  Interval training as an alternative modality to continuous exercise in patients with COPD , 2002, European Respiratory Journal.

[463]  O. Johnell,et al.  Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler® , 2002, European Respiratory Journal.

[464]  Toru Oga,et al.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.

[465]  G. Della Cioppa,et al.  Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. , 2002, Chest.

[466]  A. Diacon,et al.  Functional evaluation before lung resection. , 2002, Clinics in chest medicine.

[467]  F. Maltais,et al.  Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. , 2002, American journal of respiratory and critical care medicine.

[468]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[469]  J. V. van Noord,et al.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.

[470]  Salvador Benito,et al.  Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. , 2002, JAMA.

[471]  F. Abroug,et al.  Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial , 2001, The Lancet.

[472]  P. Jones,et al.  Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.

[473]  T. Seemungal,et al.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[474]  N J Wareham,et al.  Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. , 2001, American journal of respiratory and critical care medicine.

[475]  K. Norris,et al.  The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. , 2001, The New Zealand medical journal.

[476]  N. Anthonisen,et al.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.

[477]  R. Zuwallack,et al.  Salmeterol plus theophylline combination therapy in the treatment of COPD. , 2001, Chest.

[478]  J. Finnerty,et al.  The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. , 2001, Chest.

[479]  P. Anderson,et al.  Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial , 2001, The Lancet.

[480]  A. Kelly,et al.  How accurate are pulse oximeters in patients with acute exacerbations of chronic obstructive airways disease? , 2001, Respiratory medicine.

[481]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[482]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[483]  Sally J. Singh,et al.  A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease , 2001, Thorax.

[484]  A. Giobbie-Hurder,et al.  Effectiveness of team-managed home-based primary care: a randomized multicenter trial. , 2000, JAMA.

[485]  D. Niewoehner,et al.  Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial. , 2000, American journal of respiratory and critical care medicine.

[486]  H. Magnussen,et al.  Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[487]  C. Bucknall,et al.  Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial , 2000, Thorax.

[488]  J. Bourbeau,et al.  Inhaled tiotropium for stable chronic obstructive pulmonary disease. , 2000, The Cochrane database of systematic reviews.

[489]  M. Miravitlles,et al.  Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. , 2000, Chest.

[490]  T. Kuriyama,et al.  Effects of Hemoglobin on Pulmonary Arterial Pressure and Pulmonary Vascular Resistance in Patients with Chronic Emphysema , 2000, Respiration.

[491]  R. Stockley,et al.  Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care , 2000, Thorax.

[492]  R. Stockley,et al.  Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.

[493]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[494]  R. Rodríguez-Roisín,et al.  Toward a consensus definition for COPD exacerbations. , 2000, Chest.

[495]  M J Tobin,et al.  How is mechanical ventilation employed in the intensive care unit? An international utilization review. , 2000, American journal of respiratory and critical care medicine.

[496]  T. Seemungal,et al.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[497]  W. Hop,et al.  Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. , 2000, The European respiratory journal.

[498]  J. V. van Noord,et al.  A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease , 2000 .

[499]  C F Donner,et al.  Physiologic determinants of ventilator dependence in long-term mechanically ventilated patients. , 2000, American journal of respiratory and critical care medicine.

[500]  C. C. Christensen,et al.  Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude. , 2000, The European respiratory journal.

[501]  N. Payne,et al.  Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.

[502]  N. Adair,et al.  Exercise rehabilitation and chronic obstructive pulmonary disease stage. , 1999, American journal of respiratory and critical care medicine.

[503]  N. Gross,et al.  Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium. , 1999, American journal of respiratory and critical care medicine.

[504]  R. Stockley,et al.  The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. , 1999, American journal of respiratory and critical care medicine.

[505]  L. Davies,et al.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.

[506]  M. Miravitlles,et al.  Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. , 1999, Chest.

[507]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[508]  E. Wouters,et al.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[509]  D. Niewoehner,et al.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.

[510]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[511]  J. Vestbo,et al.  Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. , 1999, The European respiratory journal.

[512]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[513]  F. Maltais,et al.  Aerobic and strength training in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[514]  J. Wilson,et al.  Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. , 1999, Chest.

[515]  A. Hardman,et al.  The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. , 1999, Thorax.

[516]  P. Young,et al.  Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme. , 1999, Australian and New Zealand journal of medicine.

[517]  J. Ruiz,et al.  Risk factors for lower airway bacterial colonization in chronic bronchitis. , 1999, The European respiratory journal.

[518]  T. Witek,et al.  Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. , 1999, Life sciences.

[519]  C. van Weel,et al.  Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. , 1998, American journal of respiratory and critical care medicine.

[520]  M J Connolly,et al.  The effect of walking aids on exercise capacity and oxygenation in elderly patients with chronic obstructive pulmonary disease. , 1998, Age and ageing.

[521]  R. Phillips,et al.  A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. , 1998, The American journal of medicine.

[522]  J Vestbo,et al.  A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.

[523]  N. Gross,et al.  Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary Disease , 1998, Respiration.

[524]  L. Boulet,et al.  Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. , 1998, Chest.

[525]  P. Jones,et al.  Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. , 1998, The European respiratory journal.

[526]  P. Enright,et al.  Long-term particulate and other air pollutants and lung function in nonsmokers. , 1998, American journal of respiratory and critical care medicine.

[527]  M. Estenne,et al.  International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[528]  J. Gravil,et al.  Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service , 1998, The Lancet.

[529]  D. Gruson,et al.  Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency. , 1998, The European respiratory journal.

[530]  C. Sanguinetti,et al.  Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[531]  G. Criner,et al.  Effect of lung volume reduction surgery on diaphragm strength. , 1998, American journal of respiratory and critical care medicine.

[532]  R. Rodríguez-Roisín,et al.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.

[533]  H. Folgering,et al.  Pulmonary rehabilitation in chronic obstructive pulmonary disease. , 1998, The European respiratory journal.

[534]  H. Fessler,et al.  Lung volume reduction surgery and airflow limitation. , 1998, American journal of respiratory and critical care medicine.

[535]  W. Stalman,et al.  Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. , 1998, Journal of epidemiology and community health.

[536]  J. Collet,et al.  Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.

[537]  J. M. FitzGerald,et al.  Bronchodilator delivery in acute airflow obstruction. A meta-analysis. , 1997, Archives of internal medicine.

[538]  A. Jones,et al.  NO: COPD and beyond , 1997, Thorax.

[539]  F. Martinez,et al.  Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. , 1997, American journal of respiratory and critical care medicine.

[540]  J. Barberà,et al.  Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. , 1997, The European respiratory journal.

[541]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[542]  M. Wittmann.  [Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease]. , 1997, Pneumologie.

[543]  A. Morice,et al.  An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) , 1997, The European respiratory journal.

[544]  C. Kim,et al.  Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease. , 1997, American journal of respiratory and critical care medicine.

[545]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[546]  W. Knaus,et al.  Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. , 1996, JAMA.

[547]  V M Hawthorne,et al.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study , 1996, BMJ.

[548]  J. Crowley,et al.  Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.

[549]  M. Decramer,et al.  Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[550]  D. Postma,et al.  Effects of long-term treatment with corticosteroids in COPD. , 1996, Chest.

[551]  J. Barberà,et al.  Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease , 1996, The Lancet.

[552]  M. Svartengren,et al.  Repeatability of airway deposition and tracheobronchial clearance rate over three days in chronic bronchitis. , 1995, The European respiratory journal.

[553]  J. Ruiz,et al.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.

[554]  M. Wysocki,et al.  Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. , 1995, The New England journal of medicine.

[555]  B. Celli.  Pulmonary rehabilitation in patients with COPD. , 1995, American journal of respiratory and critical care medicine.

[556]  I. Tager,et al.  Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. , 1995, American journal of respiratory and critical care medicine.

[557]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[558]  C. Ulrik.  Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. , 1995, Thorax.

[559]  N. Hill,et al.  Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. , 1995, American journal of respiratory and critical care medicine.

[560]  M. Cazzola,et al.  Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study. , 1995, Respiratory medicine.

[561]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[562]  U. Ackermann-Liebrich,et al.  Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. , 1994, American journal of respiratory and critical care medicine.

[563]  L. Brochard,et al.  Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. , 1994, American journal of respiratory and critical care medicine.

[564]  K. Nichol,et al.  The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.

[565]  T. Evald,et al.  Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. , 1994, Respiratory medicine.

[566]  M. Decramer,et al.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.

[567]  R. Sharrar,et al.  Passive smoking in obstructive respiratory disease in an industrialized urban population. , 1994, Environmental research.

[568]  T. Meyer,et al.  Noninvasive Positive Pressure Ventilation To Treat Respiratory Failure , 1994, Annals of Internal Medicine.

[569]  K. Chon,et al.  Ventilatory load characteristics during ventilatory muscle training. , 1994, American journal of respiratory and critical care medicine.

[570]  K. Chapman,et al.  Physician perceptions and management of COPD. , 1993, Chest.

[571]  J. Wedzicha,et al.  Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease , 1993, The Lancet.

[572]  S. Davies,et al.  Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failure. , 1993, European heart journal.

[573]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[574]  A. Thomson,et al.  Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. , 1993, Thorax.

[575]  M. S. Singh,et al.  Development of a shuttle walking test of disability in patients with chronic airways obstruction. , 1992, Thorax.

[576]  M. Decramer,et al.  Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma. , 1992, The American review of respiratory disease.

[577]  B. O'driscoll,et al.  A long-term prospective assessment of home nebulizer treatment. , 1992, Respiratory medicine.

[578]  A. Woodcock,et al.  Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. , 1992, The European respiratory journal.

[579]  J. Barberà,et al.  Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[580]  H. Gong.  Air travel and oxygen therapy in cardiopulmonary patients. , 1992, Chest.

[581]  B. Berg,et al.  Oxygen supplementation during air travel in patients with chronic obstructive lung disease. , 1992, Chest.

[582]  L. Cinotti,et al.  Changes in the distribution of ventilation and perfusion associated with separation from mechanical ventilation in patients with obstructive pulmonary disease. , 1991, Anesthesiology.

[583]  K. Murphy,et al.  The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. , 1991, The American review of respiratory disease.

[584]  K. Godfrey,et al.  Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. , 1991, BMJ.

[585]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[586]  N. Eiser,et al.  Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome. , 1991, The European respiratory journal.

[587]  A I Mushlin,et al.  The necessary length of hospital stay for chronic pulmonary disease. , 1991, JAMA.

[588]  Y. Scherer,et al.  Can a Pulmonary Health Teaching Program Alter Patients’ Ability to Cope with COPD? , 1991, Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses.

[589]  C. van Weel,et al.  Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. , 1991, Thorax.

[590]  A. Tattersfield,et al.  Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. , 1991, The European respiratory journal.

[591]  J. Fagon,et al.  Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. , 1990, The American review of respiratory disease.

[592]  M. Teghtsoonian,et al.  Distinguishable types of dyspnea in patients with shortness of breath. , 1990, The American review of respiratory disease.

[593]  B. Lipworth,et al.  Hypokalemic and ECG sequelae of combined beta-agonist/diuretic therapy. Protection by conventional doses of spironolactone but not triamterene. , 1990, Chest.

[594]  A. Connors,et al.  Theophylline concentrations in patients with acute exacerbation of COPD. , 1990, The American journal of emergency medicine.

[595]  M. Wakefield,et al.  “Sick of Smoking”: evaluation of a targeted minimal smoking cessation intervention in general practice , 1990, The Medical journal of Australia.

[596]  J. Theodore,et al.  Lung transplantation comes of age. , 1990, The New England journal of medicine.

[597]  P. Schnohr,et al.  Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. , 1990, The American review of respiratory disease.

[598]  S. Woolf,et al.  Report of the US Preventive Services Task Force. , 1990, JAMA.

[599]  J. Roca,et al.  Ventilation-perfusion mismatching in chronic obstructive pulmonary disease during ventilator weaning. , 1989, The American review of respiratory disease.

[600]  M. Aubier,et al.  A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. , 1989, The New England journal of medicine.

[601]  T. Petty,et al.  Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. , 1989, The American review of respiratory disease.

[602]  A. Connors,et al.  Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease. , 1989, Annals of emergency medicine.

[603]  E. Daviskas,et al.  Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. , 1989, Thorax.

[604]  H. Chrystyn,et al.  Dose response relation to oral theophylline in severe chronic obstructive airways disease. , 1988, BMJ.

[605]  J. Britton,et al.  High-dose inhaled albuterol in severe chronic airflow limitation. , 1988, The American review of respiratory disease.

[606]  R. Berger,et al.  Effect of inhaled metaproterenol on exercise performance in patients with stable "fixed" airway obstruction. , 1988, The American review of respiratory disease.

[607]  J. Fredberg,et al.  Relationship between maximal expiratory flows and lung volumes in growing humans. , 1988, Journal of applied physiology.

[608]  M. Aubier.  Pharmacotherapy of respiratory muscles. , 1988, Clinics in chest medicine.

[609]  J. Moxham.  Aminophylline and the respiratory muscles: an alternative view. , 1988, Clinics in chest medicine.

[610]  J. Montserrat,et al.  Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. , 1988, The European respiratory journal.

[611]  R N Battista,et al.  Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. , 1988, JAMA.

[612]  J. B. Rasmussen,et al.  Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. , 1988, The European respiratory journal.

[613]  G. Guyatt,et al.  A controlled trial of ambroxol in chronic bronchitis. , 1987, Chest.

[614]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[615]  F. Speizer,et al.  The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. , 1987, The American review of respiratory disease.

[616]  J. Moxham,et al.  Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. , 1987, Chest.

[617]  N. Anthonisen,et al.  Airways obstruction and the risk for lung cancer. , 1987, Annals of internal medicine.

[618]  P. Holt.  Immune and inflammatory function in cigarette smokers. , 1987, Thorax.

[619]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[620]  K P Offord,et al.  Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. , 1986, Annals of internal medicine.

[621]  A Rossi,et al.  Respiratory mechanics in mechanically ventilated patients with respiratory failure. , 1985, Journal of applied physiology.

[622]  D. Taylor,et al.  The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. , 1985, The American review of respiratory disease.

[623]  M. Aubier,et al.  Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. , 1984, The New England journal of medicine.

[624]  G. Boman,et al.  Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. , 1983, European journal of respiratory diseases.

[625]  A. Woodcock,et al.  Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. , 1981, The New England journal of medicine.

[626]  Cotes Je,et al.  LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA Report of the Medical Research Council Working Party , 1981, The Lancet.

[627]  P. Vacek,et al.  Evaluation of a community-based education program for individuals with chronic obstructive pulmonary disease. , 1980, Journal of rehabilitation.

[628]  C. Husten,et al.  How to help your patients stop smoking. , 1978, American family physician.

[629]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[630]  J. Mead,et al.  Variability of maximum expiratory flow-volume curves. , 1974, Journal of applied physiology.

[631]  D. Smith,et al.  Five-year winter chemoprophylaxis for chronic bronchitis , 1969, British medical journal.

[632]  H. C. Couch.  Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. A report to the Medical Research Council by their working party on trials of chemotherapy in early chronic bronchitis. , 1966, British medical journal.

[633]  Meilan K. Han,et al.  Non-Invasive Imaging Biomarker Identifies Small Airway Damage in Severe COPD. , 2019, American journal of respiratory and critical care medicine.

[634]  Anne Holland,et al.  Pulmonary Rehabilitation Exercise Prescription in Chronic Obstructive Pulmonary Disease: Review of Selected Guidelines: AN OFFICIAL STATEMENT FROM THE AMERICAN ASSOCIATION OF CARDIOVASCULAR AND PULMONARY REHABILITATION. , 2016, Journal of cardiopulmonary rehabilitation and prevention.

[635]  A. Schols,et al.  The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review. , 2016, COPD.

[636]  M. Miravitlles,et al.  Variability of Respiratory Symptoms in Severe COPD , 2012 .

[637]  P. Poole,et al.  Tiotropium versus placebo for chronic obstructive pulmonary disease. , 2012, The Cochrane database of systematic reviews.

[638]  D. Niewoehner,et al.  Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD. , 2012, Respiratory medicine.

[639]  C. Cates,et al.  Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease. , 2011, The Cochrane database of systematic reviews.

[640]  P. Poole,et al.  Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. , 2010, The Cochrane database of systematic reviews.

[641]  Kazuhiro Ito,et al.  Translating Basic Research Into Clinical Practice COPD as a Disease of Accelerated Lung Aging * , 2009 .

[642]  J. Steurer,et al.  Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. , 2009, The Cochrane database of systematic reviews.

[643]  J. A. Maurer.  Interval versus Continuous High-Intensity Exercise in Chronic Obstructive Pulmonary Disease: A Randomized Trial , 2008 .

[644]  T. Seemungal,et al.  The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. , 2008, American journal of respiratory and critical care medicine.

[645]  D. Jarvis,et al.  Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. , 2007, American journal of respiratory and critical care medicine.

[646]  D. Hosmer,et al.  Increasing the efficacy of physician-delivered smoking interventions , 2007, Journal of General Internal Medicine.

[647]  V. Backer,et al.  The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. , 2007, Respiratory medicine.

[648]  J. Maurer.  Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator: A Randomized Trial , 2007 .

[649]  G. Valdivia,et al.  Diagnostic labeling of COPD in five Latin American cities. , 2007, Chest.

[650]  T. Lasserson,et al.  Inhaled corticosteroids for stable chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[651]  F. Maltais,et al.  Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease A Randomized Trial , 2007 .

[652]  I. Rahman.  Oxidative stress in pathogenesis of chronic obstructive pulmonary disease , 2007, Cell Biochemistry and Biophysics.

[653]  T. Lasserson,et al.  Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[654]  P. Tønnesen,et al.  Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. , 2006, Chest.

[655]  P. Schnohr,et al.  Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study , 2006, Thorax.

[656]  S. Berk,et al.  A case-control study on the effect of exposure to different substances on the development of COPD. , 2006, Annals of epidemiology.

[657]  L. Joossens,et al.  TOBACCO PRODUCT REGULATION , 2006 .

[658]  T. Todisco,et al.  Mild prematurity and respiratory functions , 2005, European Journal of Pediatrics.

[659]  H. Date,et al.  [Lung transplantation]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[660]  B. Grant,et al.  Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[661]  N. Hanania,et al.  The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. , 2003, Chest.

[662]  D. Brooks,et al.  Nutritional supplementation for stable chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.

[663]  A. Laupacis,et al.  Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. , 1999, Chest.

[664]  N. Ambrosino,et al.  Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. , 1999, The European respiratory journal.

[665]  D. Postma,et al.  Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. , 1999, The New England journal of medicine.

[666]  E. Weitzenblum,et al.  Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[667]  M. Shulman,et al.  Preoperative pulmonary evaluation. , 1999 .

[668]  Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a consensus conference report. , 1999, Chest.

[669]  N. Anthonisen.  OM-8BV for COPD. , 1997, American journal of respiratory and critical care medicine.

[670]  Ose,et al.  A COMPARISON OF FOUR METHODS OF WEANING PATIENTS FROM MECHANICAL VENTILATION , 1997 .

[671]  S. Weingarten,et al.  Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. , 1997, Chest.

[672]  P. Honeyman,et al.  Effect of a walking aid on disability, oxygenation, and breathlessness in patients with chronic airflow limitation. , 1996, Journal of cardiopulmonary rehabilitation.

[673]  L. Allegra,et al.  Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial. , 1996, Respiration; international review of thoracic diseases.

[674]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[675]  J. Cooper,et al.  Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. , 1995, The Journal of thoracic and cardiovascular surgery.

[676]  P. Calverley.  Symptomatic Bronchodilator Treatment , 1995 .

[677]  P. Barnes.  Bronchodilators: Basic Pharmacology , 1995 .

[678]  W. Dupont,et al.  A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. , 1994, The Journal of infectious diseases.

[679]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[680]  D. Georgopoulos.  Symptoms and signs of COPD , 1991 .

[681]  R. Kaplan,et al.  Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status. , 1990, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[682]  T. Pechacek,et al.  Physician-initiated smoking cessation program: the National Cancer Institute trials. , 1990, Progress in clinical and biological research.

[683]  T. Petty.  The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. , 1990, Chest.

[684]  D. Niewoehner,et al.  Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. , 1987, British journal of diseases of the chest.

[685]  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. , 1980, Annals of internal medicine.